Wendy K.D. Selig is Founder and CEO of WSCollaborative, a firm that focuses on defining and implementing strategies for establishing winning cross-sector collaborations in the health care arena. Selig’s clients include non-profit organizations, trade associations and leading pharmaceutical and biotech companies. She is known for her collaborative approach to engagement, with a record of “connecting the dots” and fostering novel partnerships.
Selig is currently a member of the Board of Directors of the Rising Tide Foundation for Clinical Cancer Research (RTFCCR).
From 2009-2015, Selig served as President and CEO of the Melanoma Research Alliance (MRA), where she led and managed MRA’s strategic priorities, research portfolio, engagement with corporate and non-profit Allies, and day-to-day operations. MRA, founded by Debra and Leon Black under the auspices of the Milken Institute, is the largest private funder of melanoma research.
Selig has held leadership roles in numerous coalitions, including President of the National Coalition of cancer Research (NCCR), founding president of United for Medical Research (UMR) and chair of One Voice Against Cancer (OVAC). She has served on the National Cancer Institute (NCI) Director's Consumer Liaison Group (DCLG), the Patient Leadership Council of the Clinical Trials Transformation Initiative (CTTI), the Government Affairs Committee of the Prostate Cancer Foundation (PCF), and the National Comprehensive Cancer Network’s (NCCN) Tissue Allocation Subcommittee.
Prior to joining the MRA, Selig spent nearly a decade in leadership positions at the American Cancer Society (the Society) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN) and 12 years as a senior staff member on Capitol Hill.
A native of Princeton, NJ, Selig is a Magna Cum Laude graduate of Princeton University and holds a Masters in Science (With Distinction) from Northwestern University’s Medill School of Journalism. She and her husband Michael live with their two children in McLean, VA.
Selig is currently a member of the Board of Directors of the Rising Tide Foundation for Clinical Cancer Research (RTFCCR).
From 2009-2015, Selig served as President and CEO of the Melanoma Research Alliance (MRA), where she led and managed MRA’s strategic priorities, research portfolio, engagement with corporate and non-profit Allies, and day-to-day operations. MRA, founded by Debra and Leon Black under the auspices of the Milken Institute, is the largest private funder of melanoma research.
Selig has held leadership roles in numerous coalitions, including President of the National Coalition of cancer Research (NCCR), founding president of United for Medical Research (UMR) and chair of One Voice Against Cancer (OVAC). She has served on the National Cancer Institute (NCI) Director's Consumer Liaison Group (DCLG), the Patient Leadership Council of the Clinical Trials Transformation Initiative (CTTI), the Government Affairs Committee of the Prostate Cancer Foundation (PCF), and the National Comprehensive Cancer Network’s (NCCN) Tissue Allocation Subcommittee.
Prior to joining the MRA, Selig spent nearly a decade in leadership positions at the American Cancer Society (the Society) and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN) and 12 years as a senior staff member on Capitol Hill.
A native of Princeton, NJ, Selig is a Magna Cum Laude graduate of Princeton University and holds a Masters in Science (With Distinction) from Northwestern University’s Medill School of Journalism. She and her husband Michael live with their two children in McLean, VA.
Speaking In
11:20 AM - 12:30 PM
Tuesday, November 19